MAPT and Alzheimer disease: Second, taking advantage of the recently developed tau PET tracer [18F]APN‐1607 (formerly known as [18F]‐PM‐PBB3), which appears to bind to both AD and non‐AD tau,31 we investigated in vivo correlates of the tau pathology observed in our histopathological examinations.